Work

Growth Hormone Receptor in Melanoma: A Unique Approach to Therapy

Year: 2016
Type: article
Abstract: Human melanomas are one of the most therapy resistant types of cancer, expressing a repertoire of mechanisms for drug resistance.Intracellular signaling networks used by the melanoma cells for active proliferation, migration, invasion, therapy resistance and metastases happen to strongly overlap with those regulated by the human growth hormone (hGH).Indeed consistently high levels of GH receptor (GHR) expression have been observed in almost all melanoma cell lines in the NCI60 human cancer panel.There are no comprehensive studies investigating the effects of GH action or GHR antagonism on the GH-responsive intracellular signaling pathways and downstream effects in human melanoma.Here we report for the first time, a detailed analysis of the effect of siRNA mediated GHR knock-down (KD) and effect of hGH on the intracellular signaling and downstream phenotypes in human melanoma cells.We report the existence of an autocrine loop of hGH-GHR in the aforesaid human melanoma cell lines, changes observed in relevant intracellular signaling pathways, RNA transcript level changes observed in multiple key modulators of the GH/GHR axis.Phosphorylation states of the JAK2, SRC, STAT1, 3, and 5, p44/42-MAPK, AKT and mTOR increased in a dose-dependent manner with hGH stimulation and were significantly attenuated by GHR-KD.Differential yet significant changes were observed in the relative mRNA transcript levels of prolactin (PRL), insulin and related growth
Institution: Ohio University
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W2600287551
FWCI:
Cites: 272
Cited by:
Related to: 10